Fundz

Cambrex Completes Acquisition Of Snapdragon Chemistry, A Leader In Continuous Flow Api Development Services

PRIVATEJan 18, 2023

Acquiring Company

Cambrex

Acquired Company

Snapdragon Chemistry

ManufacturingHealth CareScience And EngineeringManufacturingInformation TechnologyHardware

Description

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.

Quick answer

Cambrex is acquiring Snapdragon Chemistry, announced January 18, 2023.

How much did Cambrex pay for Snapdragon Chemistry?
The deal value was not disclosed.
What does Cambrex do?
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle.

Source: Fundz verified event record.

Other recent acquisitions in Science And Engineering and Hardware

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Cambrex, and when

When Cambrex changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Cambrex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cambrex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cambrex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cambrex

About

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,200 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cambrex makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cambrex's next move

Learn about Strategic plan

Frequently asked

Who acquired Snapdragon Chemistry?

Snapdragon Chemistry was acquired by Cambrex. The deal was reported on January 18, 2023. Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. Cambrex is privately held and operates in Manufacturing.

When did Cambrex acquire Snapdragon Chemistry?

Cambrex's acquisition of Snapdragon Chemistry was reported on January 18, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Snapdragon Chemistry do?

Founded in 2014 out of MIT and Boston University, Snapdragon Chemistry designs practical manufacturing solutions for challenging chemical processes. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.